EM
Estharla Madhu Rekha
National Institute of Pharmaceutical Education and Research, Birla Institute of Technology and Science - Hyderabad Campus, Sri Venkateswara Institute of Medical Sciences
0000-0002-0849-2666
Employment
-
National Institute of Pharmaceutical Education and Research Project Associate2022 - Present
-
Birla Institute of Technology and Science - Hyderabad Campus Junior Research Fellow2016 - 2020
Education
-
Sri Venkateswara Institute of Medical Sciences MSc2012 - 2014
Projects & Funding
Projects & funding information is unavailable.
Publications (15)
- N‐Substituted piperazine‐coupled imidazo[2,1‐b]thiazoles as inhibitors of Mycobacterium tuberculosis: Synthesis, evaluation, and docking studies Save
- In vitro and in silico exploration of newly synthesized triazolyl- isonicotinohydrazides as potent antitubercular agents Save
- Design, synthesis and antitubercular assessment of 1, 2, 3-triazole incorporated thiazolylcarboxylate derivatives Save
- Aryl-n-hexanamide linked enaminones of usnic acid as promising antimicrobial agents Save
- Design and synthesis of novel quinazolinyl-bisspirooxindoles as potent anti-tubercular agents: an ultrasound-promoted methodology. Save
- Design, synthesis, and in vitro biological evaluation of dehydroaripiprazole derivatives as antituberculosis agents and molecular docking study Save
- Design and synthesis of new 3-((7-chloroquinolin-4-yl)amino)thiazolidin-4-one analogs as Mycobacterium tuberculosis DNA gyrase inhibitors Save
- S-alkylated thiosemicarbazone derivatives: Synthesis, crystal structure determination, antimicrobial activity evaluation and molecular docking studies Save
- Synthesis of novel 4,5‐dihydropyrrolo[1,2‐a]quinoxalines, pyrrolo[1,2‐a]quinoxalin]‐2‐ones and their antituberculosis and anticancer activity Save
- Anti-mycobacterial activity of two natural Bisanthraquinones:(+)-1, 1′- Bislunatin and (+)-2, 2′-Epicytoskyrin A Save